Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Sutro Biopharma (STRO) Other Operating Expenses (2025)

Sutro Biopharma (STRO) has disclosed Other Operating Expenses for 1 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses changed N/A to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$9.8 million for FY2025, N/A changed from the prior year.
  • Other Operating Expenses hit $2.8 million in Q4 2025 for Sutro Biopharma, up from $2.2 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $16.8 million in Q1 2025 to a low of $2.2 million in Q3 2025.